Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Weekly treatment with a combination of bortezomib and bendamustine in relapsed or refractory indolent non-Hodgkin lymphoma.

× No keyword cloud information.

3 in total

Review 1. Bendamustine: a review of its use in the management of indolent non-Hodgkin's lymphoma and mantle cell lymphoma.

Authors: Karly P Garnock-Jones
Journal: Drugs Date: 2010-09-10 Impact factor: 9.546

2. The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphoma.

Authors: Jonathan W Friedberg; Julie M Vose; Jennifer L Kelly; Faith Young; Steven H Bernstein; Derick Peterson; Lynn Rich; Susan Blumel; Nicole K Proia; Jane Liesveld; Richard I Fisher; James O Armitage; Steven Grant; John P Leonard
Journal: Blood Date: 2011-01-14 Impact factor: 22.113

3. Bendamustine: safety and efficacy in the management of indolent non-hodgkins lymphoma.

Authors: Nishant Tageja
Journal: Clin Med Insights Oncol Date: 2011-05-18

3 in total